Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationHematopoietic Stem CellsHematopoietic Stem Cell MobilizationStem CellsTransplantation, AutologousBone MarrowBone Marrow TransplantationBone Marrow CellsTransplantation, HomologousGranulocyte Colony-Stimulating FactorLeukapheresisAntigens, CD34Transplantation ConditioningBlood Component RemovalGraft vs Host DiseaseHematologic NeoplasmsHematopoiesisStem Cell TransplantationGraft SurvivalMelphalanCyclophosphamideCombined Modality TherapyCell DifferentiationBusulfanBone and BonesBlood CellsEmbryonic Stem CellsCord Blood Stem Cell TransplantationMultiple MyelomaColony-Forming Units AssayAdult Stem CellsBlood Cell CountStem Cell NicheTissue DonorsAntineoplastic Combined Chemotherapy ProtocolsTransplantation ChimeraCell LineageTreatment OutcomeFlow CytometryBone Marrow DiseasesWhole-Body IrradiationCell SeparationStem Cell FactorCells, CulturedMyeloablative AgonistsBone Marrow PurgingLymphoma, Non-HodgkinLeukemiaPluripotent Stem CellsRecurrenceHistocompatibilityEtoposideMice, Inbred C57BLAntineoplastic Agents, AlkylatingThiotepaMultipotent Stem CellsHistocompatibility TestingRemission InductionTime FactorsFetal BloodImmunophenotypingAntigens, CDMesenchymal Stromal CellsMesenchymal Stem Cell TransplantationAnemia, AplasticLeukemia, Myeloid, AcuteInduced Pluripotent Stem CellsNeural Stem CellsPlatelet CountTransplantation, IsogeneicRetrospective StudiesDisease-Free SurvivalBlood DonorsCell ProliferationVidarabineRecombinant ProteinsCytarabineLeukocyte CountHematologic DiseasesT-LymphocytesMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunosuppressive AgentsImmunomagnetic SeparationGranulocytesIfosfamideSurvival RateInfectionLeukocytes, MononuclearCell CountSalvage TherapySurvival AnalysisMice, SCIDNeoplasmsLymphomaVincristineHodgkin DiseaseBone RemodelingLymphocyte Depletion